SSY GROUP (02005) has twelve products with fourteen specifications that are expected to win the bid for the eleventh batch of National Group Procurement of Pharmaceuticals.

08:25 28/10/2025

Stone Four Medicine Group (02005) announced that it won the bid for the 11th batch of national centralized drug procurement in China on October 27, 2025.

SSY GROUP (02005) announced that in the 11th batch of national drug centralized procurement bidding in China on October 27, 2025, the group has a total of twelve products and fourteen specifications expected to be awarded: Hydroxypropyl theoteaine injection (2ml:0.3g), Fumarate formoterol inhalation solution (2ml:20g), Fluvoxamine maleate tablets (100mg and 50mg), Clonixin Injection (8mg), Epinephrine hydrochloride injection (1ml:1mg), Bromhexine hydrochloride injection (2ml:4mg), Compound electrolyte injection (500ml), Compound electrolyte injection (II) (500ml and 1000ml), Nicardipine tablets (5mg), Terbutaline sulfate injection (1ml:0.5mg), Benidipine hydrochloride tablets (8mg), and Sodium bicarbonate injection (50ml:4.2g).

CHENGDU EXPWAY (01785) announces its performance for the first three quarters, with a net profit attributable to the parent company of 467 million yuan, a decrease of 5.31% year-on-year.

BEAUTYFARM MED (02373) repurchased 30,000 shares at a cost of approximately 917,200 Hong Kong dollars on October 28th.

HSC RESOURCES (01850) will resume trading on October 30th.

CHENGDU EXPWAY (01785) announces its performance for the first three quarters, with a net profit attributable to the parent company of 467 million yuan, a decrease of 5.31% year-on-year.

BEAUTYFARM MED (02373) repurchased 30,000 shares at a cost of approximately 917,200 Hong Kong dollars on October 28th.

HSC RESOURCES (01850) will resume trading on October 30th.